ASK4PHARMA CONSULTING
ActiveFrom the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
ASK4PHARMA CONSULTING has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €386,067. Equity is growing by about 35% per year across the filed financial years. Its solvency ranks better than 92% of 9,643 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
financial year 2025 · micro format · 28 days late
2025
31-12
Financial
Highest result from 2021 to 2025net €386,067 ▲27.5%
Net result €386,067, the highest in the series.
18-08
financial year 2024 · micro format · 18 days late
2024
31-12
Financial
Equity above €1mequity €1.1m ▲36.4%
A profit in every financial year since 2021 builds equity to €1.1m.
24-07
financial year 2023 · micro format
2023
20-06
financial year 2022 · micro format
2022
31-12
Financial
Weakest financial yearnet €231,842 ▼26.3%
Net result drops to €231,842, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €500,000equity €547,501 ▲73.4%
A profit in every financial year since 2021 builds equity to €547,501.
09-06
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank